bromodeoxyuridine has been researched along with Mixed Tumor, Mullerian in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gersell, DJ; Meyer, JS; Yim, S | 1 |
1 other study(ies) available for bromodeoxyuridine and Mixed Tumor, Mullerian
| Article | Year |
|---|---|
Cell proliferation in ovarian carcinoma: superior accuracy of S-phase fraction (SPF) by DNA labeling index versus flow cytometric SPF, lack of independent prognostic power for SPF and DNA ploidy, and limited effect of SPF on tumor growth rate.
Topics: Bromodeoxyuridine; Cell Division; DNA, Neoplasm; Female; Flow Cytometry; Humans; Middle Aged; Mixed Tumor, Mullerian; Neoplasm Staging; Ovarian Neoplasms; Peritoneal Neoplasms; Ploidies; Prognosis; S Phase; Survival Rate; Thymidine; Tritium | 2001 |